ReWalk Files For $58M NASDAQ Public Offering

July 14, 2014 | ReWalk Robotics filed for an initial public offering on NASDAQ to raise $58 million, with a company value of $250-300 million after money. According to a “Globes” report, the company recently changed its name from Argo Medical Technology to the name of its major product, the ReWalk Exoskeleton, a device that allows paraplegics to walk upright. The device was invented by Dr. Amit Goffer whose startup Odin sold to Medtronic for $9 million in 1997 and who himself is paralyzed. The ReWalk device recently received Food and Drug Administration (FDA) approval for the sale of its device in the United States.